Historial del iniciado Otro Rendimiento medio T+90
+7.1%
Sobre 16 señales de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Browse the full record of transactions filed by Dr Anne Beal. Director active across 1 company, notably GSK plc. Cumulatively, 30 disclosures have been logged. History available since 20 June 2023. The latest transaction was disclosed on 10 July 2026 (Purchase). Regulator: RNS (LSE). The full history is free.
Companies and markets linked to Dr Anne Beal Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones 30 en total
● Independent Non-Executive Director · Directivos · 10 jul 2026 · GSK plc 35 títulos @ 52,7354 GBP New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:9673287-7 ● Independent Non-Executive Director · Directivos · 10 jul 2026 · GSK plc 35 títulos @ 0,5274 GBP 0.0000% mcap 0.0% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:68763dee-a518-4ccc-8d25-48330cbfa37e-7 ● Independent Non-Executive Director · Directivos · 22 jun 2026 · GSK plc 745 títulos @ 50,6908 GBP 0.0001% mcap 94.8% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:9632737-3 ● Independent Non-Executive Director · Directivos · 22 jun 2026 · GSK plc 745 títulos @ 0,5069 GBP 0.0000% mcap 18.1% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:1cabaef6-2e05-4f58-a412-24a2f7509642-3 ● Independent Non-Executive Director · Directivos · 9 abr 2026 · GSK plc 32 títulos @ 0,5894 GBP 0.0000% mcap 1.1% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-13 ● Independent Non-Executive Director · Directivos · 20 mar 2026 · GSK plc 196 títulos @ 0,518 GBP 0.0000% mcap 6.0% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:c2055913-103f-4927-b6f8-8f0835af9e8e-4 ● Independent Non-Executive Director · Directivos · 9 ene 2026 · GSK plc 31 títulos @ 0,5042 GBP 0.9% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-37 ● Independent Non-Executive Director · Directivos · 19 dic 2025 · GSK plc 201 títulos @ 0,4856 GBP 5.7% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5a98a0c7-d756-450b-83e9-f26937fe1a0f-3 ● Independent Non-Executive Director · Directivos · 10 oct 2025 · GSK plc 34 títulos @ 0,4374 GBP 1.0% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5859068-28 ● Independent Non-Executive Director · Directivos · 19 sept 2025 · GSK plc 240 títulos @ 0,4074 GBP 6.6% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5830475-4 ● Independent Non-Executive Director · Directivos · 11 jul 2025 · GSK plc 35 títulos @ 0,3854 GBP 0.9% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5737340-35 ● Independent Non-Executive Director · Directivos · 20 jun 2025 · GSK plc 257 títulos @ 0,3789 GBP 7.3% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5708028-5 ● Independent Non-Executive Director · Directivos · 20 jun 2025 · GSK plc 257 títulos @ 0,3789 GBP 7.3% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5707630-5 ● Independent Non-Executive Director · Directivos · 11 abr 2025 · GSK plc 22 títulos @ 0,3414 GBP 0.6% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5617047-3 ● Independent Non-Executive Director · Directivos · 25 mar 2025 · GSK plc 970 títulos @ 0,3881 GBP 28.9% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5593269-1 ● Independent Non-Executive Director · Directivos · 20 mar 2025 · GSK plc 249 títulos @ 0,3927 GBP 13.4% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5584787-5 ● Independent Non-Executive Director · Directivos · 10 ene 2025 · GSK plc 18 títulos @ 0,3333 GBP 0.8% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5498728-19 ● Independent Non-Executive Director · Directivos · 20 dic 2024 · GSK plc 271 títulos @ 0,3381 GBP 12.7% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5479029-5 ● Independent Non-Executive Director · Directivos · 11 oct 2024 · GSK plc 14 títulos @ 0,3907 GBP 1.0% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5388451-3 ● Independent Non-Executive Director · Directivos · 23 sept 2024 · GSK plc 224 títulos @ 0,4101 GBP 17.3% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5362280-4 ● Independent Non-Executive Director · Directivos · 12 jul 2024 · GSK plc 12 títulos @ 0,3933 GBP 1.1% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5266837-13 ● Independent Non-Executive Director · Directivos · 21 jun 2024 · GSK plc 225 títulos @ 0,4076 GBP 20.8% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5235239-4 ● Independent Non-Executive Director · Directivos · 12 abr 2024 · GSK plc 9 títulos @ 0,41 GBP 0.8% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5143847-27 ● Independent Non-Executive Director · Directivos · 20 mar 2024 · GSK plc 219 títulos @ 0,419 GBP 26.6% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5116598-5 ● Independent Non-Executive Director · Directivos · 12 ene 2024 · GSK plc 6 títulos @ 0,4017 GBP 0.7% de su flujo New York Stock Exchange (XNYS)ISIN ISIN US37733W2044RNS:5034561-26 25 de 30 declaraciones
Ver más (5 restantes) About Dr Anne Beal Dr Anne Beal is a declarant who has made 28 filings in total. In her most recent filings, she purchased a total of 45471 euros worth of shares in GSK plc, with the last transaction recorded on June 24, 2026, where she bought for 43512.42 euros. Other transactions include purchases of varying amounts, as well as an other type transaction on March 28, 2025, for 450.26 euros.